Citations for
1EBAG9, SNAPIN
EBAG9 adds a new layer of control on large dense-core vesicle exocytosis via interaction with Snapin.
Ruder C, Reimer T, Delgado-Martinez I, Hermosilla R, Engelsberg A, Nehring R, Dorken B, Rehm A.
Mol Biol Cell 16(3):1245-57. Epub 2005 Jan 5. 2005
2EBAG9
Expression of EBAG9/RCAS1 is associated with advanced disease in human epithelial ovarian cancer.
Akahira JI, Aoki M, Suzuki T, Moriya T, Niikura H, Ito K, Inoue S, Okamura K, Sasano H, Yaegashi N.
Br J Cancer 90(11):2197-202. 2004
3EBAG9
The Golgi protein RCAS1 controls cell surface expression of tumor-associated O-linked glycan antigens.
Engelsberg A, Hermosilla R, Karsten U, Schulein R, Dorken B, Rehm A.
J Biol Chem 278(25):22998-3007. Epub 2003 Apr 02. 2003
4EBAG9
EBAG9/RCAS1 expression in hepatocellular carcinoma: correlation with tumour dedifferentiation and proliferation.
Aoki T, Inoue S, Imamura H, Fukushima J, Takahashi S, Urano T, Hasegawa K, Ogushi T, Ouchi Y, Makuuchi M.
Eur J Cancer 39(11):1552-61. 2003
5EBAG9
The prognostic significance of RCAS1 expression in squamous cell carcinoma of the oesophagus.
Nakakubo Y, Hida Y, Miyamoto M, Hashida H, Oshikiri T, Kato K, Suzuoki M, Hiraoka K, Ito T, Morikawa T, Okushiba S, Kondo S, Katoh H.
Cancer Lett 177(1):101-5. 2002
6EBAG9
RCAS1 is associated with ductal breast cancer progression.
Rousseau J, Tetu B, Caron D, Malenfant P, Cattaruzzi P, Audette M, Doillon C, Tremblay JP, Guerette B.
Biochem Biophys Res Commun 293(5):1544-9. 2002
7EBAG9
The tumor-associated antigen, RCAS1, can be expressed in immune-mediated diseases as well as in carcinomas of biliary tract.
Enjoji M, Nakashima M, Nishi H, Choi I, Oimomi H, Sugimoto R, Kotoh K, Taguchi K, Nakamuta M, Nawata H, Watanabe T.
J Hepatol 36(6):786-92. 2002
8EBAG9
RCAS1 expression: a potential prognostic marker for adenocarcinomas of the lung.
Oizumi S, Yamazaki K, Nakashima M, Watanabe T, Hommura F, Ogura S, Nishimura M, Dosaka-Akita H.
Oncology 62(4):333-9. 2002
9EBAG9,KCNV1,POLR2K,UBR5
An integrated physical map of 8q22-q24: use in positional cloning and deletion analysis of langer-giedion syndrome.
Hilton MJ, Gutierrez L, Zhang L, Moreno PA, Reddy M, Brown N, Tan Y, Hill A, Wells DE.
Genomics 71(2):192-9. 2001
10EBAG9
Molecular cloning and characterization of mouse EBAG9, homolog of a human cancer associated surface antigen: expression and regulation by estrogen.
Tsuchiya F, Ikeda K, Tsutsumi O, Hiroi H, Momoeda M, Taketani Y, Muramatsu M, Inoue S.
Biochem Biophys Res Commun 284(1):2-10. 2001
11EBAG9
Expression of tumor-associated antigen RCAS1 correlates significantly with poor prognosis in nonsmall cell lung carcinoma.
Izumi M, Nakanishi Y, Yoshino I, Nakashima M, Watanabe T, Hara N.
Cancer 92(2):446-51. 2001
12EBAG9
EBAG9/RCAS1 in human breast carcinoma: a possible factor in endocrine-immune interactions.
Suzuki T, Inoue S, Kawabata W, Akahira J, Moriya T, Tsuchiya F, Ogawa S, Muramatsu M, Sasano H.
Br J Cancer 85(11):1731-7. 2001
13EBAG9
RCAS1 as a tumour progression marker: an independent negative prognostic factor in gallbladder cancer.
Oshikiri T, Hida Y, Miyamoto M, Hashida H, Katoh K, Suzuoki M, Nakakubo Y, Hiraoka K, Shinohara T, Itoh T, Kondo S, Katoh H.
Br J Cancer 85(12):1922-7. 2001
14EBAG9
Promoter analysis and chromosomal mapping of human EBAG9 gene.
Ikeda K, Sato M, Tsutsumi O, Tsuchiya F, Tsuneizumi M, Emi M, Imoto I, Inazawa J, Muramatsu M, Inoue S.
Biochem Biophys Res Commun 273(2):654-60. 2000
15EBAG9
Inhibition of cell growth and induction of apoptotic cell death by the human tumor-associated antigen RCAS1.
Nakashima M, Sonoda K, Watanabe T.
Nat Med 5(8):938-42. 1999
16COX7A2L, COX7AP2, EBAG9, GRIN2D
Isolation of estrogen-responsive genes with a CpG island library.
Watanabe T, Inoue S, Hiroi H, Orimo A, Kawashima H, Muramatsu M.
Mol Cell Biol 18(1):442-9. 1998